<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202014000400003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Programa científico]]></article-title>
</title-group>
<aff id="A">
<institution><![CDATA[,  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2014</year>
</pub-date>
<volume>29</volume>
<fpage>9</fpage>
<lpage>30</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202014000400003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202014000400003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202014000400003&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[   <basefont size="3">     <p align="left"><font color="#ffffff" face="Verdana" size="1"> Programa cient&iacute;fico&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="6"> Programa cient&iacute;fico    <br>  &nbsp; </font></p>       <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>Jueves 4 de diciembre</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>       <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>Sal&oacute;n: Ball Room A&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Curso Pre Congreso &ndash; EMC &ndash; Parte I</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Estimaci&oacute;n de riesgo en cardiolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia: Bayer<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador General: Dr. Oscar Bazzino&nbsp;</i> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.30&nbsp;&nbsp;&nbsp;&nbsp;Acreditaciones&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;08.30 - 09.15&nbsp;&nbsp;&nbsp;&nbsp;<b>M&Oacute;DULO 1</b>    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Predicci&oacute;n de enfermedad cardiovascular futura en  la poblaci&oacute;n general</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Oscar Bazzino</i><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.15 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>M&Oacute;DULO 2</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Riesgo emb&oacute;lico y riesgo hemorr&aacute;gico en individuos con FA</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Horacio V&aacute;zquez</i><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.00 - 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.30 - 12.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Curso Pre Congreso &ndash; EMC &ndash; Parte II    <br>  &nbsp;&nbsp;&nbsp;&nbsp;Estimaci&oacute;n de riesgo en  cardiolog&iacute;a    ]]></body>
<body><![CDATA[<br>  </b><i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador General: Dr. Oscar Bazzino</i><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;10.30 - 11.15&nbsp;&nbsp;&nbsp;&nbsp;<b>M&Oacute;DULO 3    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evaluaci&oacute;n de riesgo de IAM y/o muerte en pacientes  que cursan     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;un s&iacute;ndrome coronario agudo</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinador: Dr. Gustavo Junker</i><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;11.15 - 12.00&nbsp;&nbsp;&nbsp;&nbsp;<b>M&Oacute;DULO 4</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Riesgo de muerte s&uacute;bita en individuos con y sin cardiopat&iacute;a estructural</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Walter Reyes Caorsi</i><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;12.30 - 14.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Terapia antiplaquetaria: &iquest;qu&eacute; f&aacute;rmaco y por cu&aacute;nto tiempo</b>?<b>&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Ariel Dur&aacute;n&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Expositor: Dr. Roberto Botelho (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Sebasti&aacute;n Olaizola, Dr. Ricardo Lluberas, Dra. M&oacute;nica Giambruno,      <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Pablo V&aacute;zquez, Dr. Sergio Montenegro (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Lunch cortes&iacute;a AstraZeneca</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;14.00 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a cardiovascular: &iquest;cu&aacute;l es la mejor para mi paciente?</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dra. Ver&oacute;nica Gonz&aacute;lez, Dr. Federico Ferrando&nbsp;</i> </font></p>      <p> </p>     <p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;<b>M&Oacute;DULO I    ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;Diagn&oacute;stico de cardiopat&iacute;a isqu&eacute;mica. A prop&oacute;sito de un caso cl&iacute;nico&nbsp;</b>  </font> </p>     <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.00 - 14.05&nbsp;&nbsp;&nbsp;&nbsp;Caso cl&iacute;nico<font color="#1f1a17" face="Courier New" size="2">    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font color="#1f1a17" face="Verdana" size="2">Presentador: Dr. Juan Torrado</font><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.05 - 14.20&nbsp;&nbsp;&nbsp;&nbsp;A favor de TAC multicorte<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Natalia Lluberas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.20 - 14.35&nbsp;&nbsp;&nbsp;&nbsp;A favor de la medicina nuclear<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gabriel Grossman (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.35 - 14.45&nbsp;&nbsp;&nbsp;&nbsp;Resumen y discusi&oacute;n con expertos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas:<font color="#1f1a17" face="Courier New" size="2"> </font><font color="#1f1a17" face="Verdana" size="2">Dr. Federico Ferrando, Dra. Luc&iacute;a Florio, Dra. Ver&oacute;nica Gonz&aacute;lez</font><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;M&Oacute;DULO II    ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;Valoraci&oacute;n y pron&oacute;stico en cardiopat&iacute;a isqu&eacute;mica. &iquest;Qu&eacute; le sucedi&oacute; a nuestro paciente?</b><font color="#1f1a17" face="Courier New" size="2"><b>&nbsp;</b></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.45 - 14.50&nbsp;&nbsp;&nbsp;&nbsp;Caso cl&iacute;nio    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: &nbsp;Dra. Valentina Lanz&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.50 - 15.05&nbsp;&nbsp;&nbsp;&nbsp;A favor de la RNM<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Diego P&eacute;rez de Arenaza (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.05 - 15.20&nbsp;&nbsp;&nbsp;&nbsp;A favor del ecoestr&eacute;s<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.<font color="#1f1a17" face="Courier New" size="2"> </font><font color="#1f1a17" face="Verdana" size="2">Alvaro Beltr&aacute;n</font><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.20 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;Resumen y discusi&oacute;n con expertos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Federico Ferrando, Dra. Luc&iacute;a Florio, Dra. Ver&oacute;nica Gonz&aacute;lez&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 15.30 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia</b>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Tomograf&iacute;a computarizada: utilidad m&aacute;s all&aacute; de la coronariograf&iacute;a</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Dr. Leonardo Rodr&iacute;guez (USA)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Sergio Vi&ntilde;as&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;16.00 - 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;16.30 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Patolog&iacute;a a&oacute;rtica aguda</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dr. Gustavo Vignolo, Dr. Gonzalo Varela</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.30 - 16.35&nbsp;&nbsp;&nbsp;&nbsp;Introducci&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gustavo Vignolo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.35 - 16.50&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n cl&iacute;nica&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gustavo Vignolo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.50 - 17.10&nbsp;&nbsp;&nbsp;&nbsp;S&iacute;ndrome a&oacute;rtico agudo: &iquest;qu&eacute; t&eacute;cnica de imagen para qu&eacute; caso?<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Leonardo Rodr&iacute;guez (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.10 - 17.30&nbsp;&nbsp;&nbsp;&nbsp;Estado actual del tratamiento intervencionista de los s&iacute;ndromes a&oacute;rticos agudos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Hugo Londero (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.30 - 17.50&nbsp;&nbsp;&nbsp;&nbsp;Caso cl&iacute;nico: Rotura traum&aacute;tica de aorta<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Sebasti&aacute;n Alonso<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.50 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;Preguntas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Leonardo Rodr&iacute;guez (USA), Dr. Hugo Londero &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Argentina), Dr. Honorio Palma (Brasil), Dr. Jorge Mayol<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 18.00 - 19.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia de Apertura</b>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Sobreviviente de los Andres. Grupos humanos en situaci&oacute;n de crisis</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Dr. Roberto Canessa<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Ariel Dur&aacute;n&nbsp; </font></p>      <p><font color="#1f1a17" face="Verdana" size="2"> <b>Sal&oacute;n: Conference&nbsp;</b> </font> </p>     <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 - 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 14.00 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Nuevas indicaciones de los programas de RCV</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Gerard Burdiat, Dr. Oscar D&iacute;az Arnesto</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.00 - 14.15&nbsp;&nbsp;&nbsp;&nbsp;Prescripci&oacute;n del ejercicio: una materia pendiente&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Cecilia del Campo&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.15 - 14.40&nbsp;&nbsp;&nbsp;&nbsp;Creando el programa de entrenamiento de ejercicio ideal para  el paciente     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;con insuficiencia card&iacute;aca: aer&oacute;bico, resistencia y m&aacute;s all&aacute;&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ross Arena (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.40 - 15.00&nbsp;&nbsp;&nbsp;&nbsp;Un ejercicio f&iacute;sico para cada edad y circunstancia&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jos&eacute; Ram&oacute;n Gonz&aacute;lez Juanatey (Espa&ntilde;a)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.00 - 15.25&nbsp;&nbsp;&nbsp;&nbsp;Los programas de salud y bienestar en el trabajo como modelo  para la     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prevenci&oacute;n primaria de la rehabilitaci&oacute;n card&iacute;aca<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ross Arena (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.25 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;Preguntas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelista: Dr. Fabio Mennitte (Argentina)&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> 15.30 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Nuevas indicaciones para programas de rehabilitaci&oacute;n cardiovascular</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ross Arena (USA)</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dra. Mar&iacute;a Dutra&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.00 - 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.30 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Resucitaci&oacute;n card&iacute;aca: &iquest;hay algo de nuevo? Logros y desaf&iacute;os</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Alvaro Niggemeyer, Dra. Andrea Simeone</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 - 16.50&nbsp;&nbsp;&nbsp;&nbsp;Resucitaci&oacute;n card&iacute;aca; experiencia nacional y perspectiva del futuro&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Fernanda Xalambr&iacute;, Dr. Alvaro Niggemeyer<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.50 - 17.10&nbsp;&nbsp;&nbsp;&nbsp;El antes y el despu&eacute;s del paro card&iacute;aco<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Alvaro Rivara , Dra. Andrea Simeone<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.10 - 17.40&nbsp;&nbsp;&nbsp;&nbsp;Estamos a un a&ntilde;o de las nuevas normas ILCOR en RC&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Sa&uacute;l Drajer (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.40 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;Datos de la vida real: testimonio de los sobrevivientes<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Inst. Pablo L&oacute;pez&nbsp; </font></p>       <p align="left">&nbsp;<font color="#1f1a17" face="Verdana" size="2"><b>Sal&oacute;n: Picasso&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 - 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 14.00 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>XXI Encuentro de Neumocardiolog&iacute;a - Parte I</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. NC. Noelia De Patti</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.00 - 14.15&nbsp;&nbsp;&nbsp;&nbsp;Apertura&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ariel Dur&aacute;n - Presidente Congreso<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. NC. Noelia De Patti - Presidente Comit&eacute;<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.15 - 14.45&nbsp;&nbsp;&nbsp;&nbsp;En qu&eacute; estamos en reanimaci&oacute;n cardiovascular b&aacute;sica<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. NC. Noelia De Patti<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositora: Dra. Andrea Simeone<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.45 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;ECG en la pr&aacute;ctica: &ldquo;Como interpretarlo y no fracasar en el intento III&rdquo;<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Lic. NC. Cristina Ekroth, Lic. NC. Pablo Marichal<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositores: Br. Romina Nogara, Br. Claudia Mart&iacute;nez, Br. Ana &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bel&eacute;n Rivero, Br. Gonzalo Est&eacute;vez, Br. Karla Garc&iacute;a&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.30 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;Shock cardiog&eacute;nico<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. NC. Lorena Larruina<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositor: Dr. Carlos Quiroga&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.00 - 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.30 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>XXI Encuentro de Neumocardiolog&iacute;a - Parte II</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. NC. Noelia De Patti</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 - 17.00&nbsp;&nbsp;&nbsp;&nbsp;PEG: &ldquo;M&aacute;s all&aacute; del infradesnivel del segmento ST&rdquo;&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Roberto Ricca, Dr. Federico Ferrando,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. NC. Cristina  Ekroth<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositor: Lic. NC. Pablo Marichal<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.00 - 17.30&nbsp;&nbsp;&nbsp;&nbsp;Imagen card&iacute;aca: &ldquo;M&aacute;s all&aacute; de la ecocardiograf&iacute;a&rdquo;<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Lic. NC. Pablo Marichal<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositores: Dra. Luc&iacute;a Florio, Dr. Gabriel Parma<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.30 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;Im&aacute;genes del navegador electro anat&oacute;mico para el diagn&oacute;stico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;de las arritmias<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. NC. Blanca Mart&iacute;nez&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositor: Lic. NC. Joaqu&iacute;n Verde<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;18.00&nbsp;&nbsp;&nbsp;&nbsp;Clausura&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. NC. Graciela Do Mato - Directora Escuela de Tecnolog&iacute;a M&eacute;dica<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. NC. Blanca Mart&iacute;nez - Secretaria Comit&eacute; Neumocardiolog&iacute;a<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. NC. Carlos Alvez - ATENCU<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>        <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp; <b>Sal&oacute;n: Matisse&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 - 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> 14.00 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Presentaci&oacute;n E-posters</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Hemodinamia</b>&nbsp;&nbsp;&nbsp;&nbsp;<i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. C&eacute;sar Pardi&ntilde;as, Dr. Pablo V&aacute;zquez, Dr. Roberto Botelho  (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 - 14.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;16&nbsp;&nbsp;&nbsp;&nbsp;Estrategia terap&eacute;utica percut&aacute;nea en el IAM en dos tiempos: arteria     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;culpable con ATC primaria y lesiones residuales en diferido<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Daniela Korytnicki<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.15 - 14.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;19&nbsp;&nbsp;&nbsp;&nbsp;Diferencias de g&eacute;nero en los pacientes tratados con angioplastia primaria<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Carolina Artucio<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.30 - 14.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;29&nbsp;&nbsp;&nbsp;&nbsp;Uso de Inhibidores IIb/IIIa como tratamiento coadyuvante al     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;tratamiento endovascular en la isquemia cr&iacute;tica de miembros inferiores    ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;en  pacientes con angioplastia inicial inefectiva. Primera experiencia     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;nacional&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Sebasti&aacute;n Olaizola<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.45 - 15.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;39&nbsp;&nbsp;&nbsp;&nbsp;Ticagrelor asociado a &aacute;cido acetil salic&iacute;lico en pacientes con sindrome     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;coronario agudo intervenidos con angioplastia coronaria.     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nuestra  experiencia inicial.<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Dayana Acosta&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.00 - 15.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;43&nbsp;&nbsp;&nbsp;&nbsp;Angiograf&iacute;a y necesidad de revascularizaci&oacute;n postfibrin&oacute;lisis en IAM&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Leandro Jubany<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.15 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;48&nbsp;&nbsp;&nbsp;&nbsp;Impacto de la complejidad anat&oacute;mica coronaria en la mortalidad a     ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mediano plazo en pacientes con cirug&iacute;a de revascularizaci&oacute;n     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mioc&aacute;rdica  previa sometidos a ATC&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Sebasti&aacute;n Lluberas&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cardiolog&iacute;a Cl&iacute;nica</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentador: Dr. Fernando Kuster<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.30 - 15.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;49&nbsp;&nbsp;&nbsp;&nbsp;Evoluci&oacute;n a 6 meses de pacientes con estrategia invasiva precoz     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;tratados con ATC en el s&iacute;ndrome coronario agudo sin elevaci&oacute;n del ST.<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Mar&iacute;a Jos&eacute; Sommer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.45 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;50&nbsp;&nbsp;&nbsp;&nbsp;Seguimiento de pacientes con s&iacute;ndrome coronario agudo con elevaci&oacute;n    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; del ST e indicaci&oacute;n de alta precoz luego de angioplastia primaria&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Mar&iacute;a Jos&eacute; Sommer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.00 - 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.30 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio</b>&nbsp; </font></p>      <p><font color="#1f1a17" face="Verdana" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;Cardiolog&iacute;a Pedi&aacute;trica</b><font color="#1f1a17" face="Courier New" size="2"><i>.</i></font><font color="#1f1a17" face="Verdana" size="2"> <b>Casos cl&iacute;nicos</b></font><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Ruben Leone&nbsp; </font></p>       <p align="left"><font color="#1f1a17" face="Verdana" size="2">     <br>  </font><font color="#1f1a17" face="Verdana" size="2"> <b>Sal&oacute;n: Ball Room C&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;J<b>ornadas de Enfermer&iacute;a Intervencionista (SOLACI) - Parte I</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Presidente: Lic. Regina Yarza</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.20&nbsp;&nbsp;&nbsp;&nbsp;Avances en hemodin&aacute;mica&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Fernando Orsi (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.25 - 08.45&nbsp;&nbsp;&nbsp;&nbsp;Aspectos t&eacute;cnicos en el implante de v&aacute;lvula a&oacute;rtica transcat&eacute;ter<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Ender Salto Sarmiento (Venezuela)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.50 - 09.10&nbsp;&nbsp;&nbsp;&nbsp;Enfermedad carot&iacute;dea: diferentes m&eacute;todos de detecci&oacute;n<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Fernando Orsi (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.15 - 09.35&nbsp;&nbsp;&nbsp;&nbsp;Enfermedad carot&iacute;dea despu&eacute;s del crest<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Margarita Garc&iacute;a (Costa Rica)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.40 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;Protecci&oacute;n radiol&oacute;gica. Mito, realidad<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Victor Bonvini (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.00 - 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.30 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Jornadas de Enfermer&iacute;a Intervencionista (SOLACI) - Parte II</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Presidente: Lic. Regina Yarza</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 - 10.50&nbsp;&nbsp;&nbsp;&nbsp;Quimioembolizaci&oacute;n hep&eacute;tica&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Mara Ang&eacute;lica V&aacute;zquez (Bolivia)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.55 - 11.15&nbsp;&nbsp;&nbsp;&nbsp;Embolizaci&oacute;n de arterias uterinas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Margarita Garc&iacute;a (Costa Rica)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.20 - 11.40&nbsp;&nbsp;&nbsp;&nbsp;Aneurisma toraco abdominales con compromiso de arterias viscerales<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Fernando Orsi (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.45 - 12.05&nbsp;&nbsp;&nbsp;&nbsp;Antiagregaci&oacute;n plaquetaria en el s&iacute;ndrome coronario<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Marcela Rodr&iacute;guez (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> 12.30 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>XV Jornadas de Enfermer&iacute;a en Cardiolog&iacute;a - Parte I</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. Gabriela Dotti</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.30 - 12.45:&nbsp;&nbsp;&nbsp;&nbsp;Apertura    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Gabriela Dotti&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.45 - 13.30&nbsp;&nbsp;&nbsp;&nbsp;Seguridad en el usuario cardiovascular<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Roc&iacute;o Gonz&aacute;lez<font color="#1f1a17" face="Courier New" size="2">    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font color="#1f1a17" face="Verdana" size="2">Coordinadora: Lic. Cristina Rodr&iacute;guez</font><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;13.30 - 14.00&nbsp;&nbsp;&nbsp;&nbsp;Indicadores de calidad en pacientes con patolog&iacute;a cardiovascular<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Estefan&iacute;a Bidart, Lic. Alicia Cisneros, Lic. Blanca Sarno, Lic. Mar&iacute;a Tessadri,    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Cindy Montero, Lic. Vanessa Caballero, Lic. Jos&eacute; Castelao,  Lic. Pablo Gallino,    ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Carlos Muniz, Lic. Carlo Pereira&nbsp; </font></p>      <p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 - 14.30&nbsp;&nbsp;&nbsp;&nbsp;Diabetes y coraz&oacute;n, una mirada desde el primer nivel de atenci&oacute;n.     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Leonilda De Franco, Lic. Andrea Arroyo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.30 - 15.00&nbsp;&nbsp;&nbsp;&nbsp;Marihuana y coraz&oacute;n. &Eacute;poca de cannabis<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Olga Ara&uacute;jo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.00 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;Lesiones vinculadas con la dependencia en el posoperatorio  de cirug&iacute;a card&iacute;aca<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Cristina de Vilas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.30 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;Como se comporta el coraz&oacute;n en el paciente quemado cr&iacute;tico<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. &nbsp;Andrea Vidal, Lic. Mar&iacute;a Pailex<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.00 - 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.30 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>XV Jornadas de Enfermer&iacute;a en Cardiolog&iacute;a - Parte II</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. Gabriela Dotti</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 - 17.00&nbsp;&nbsp;&nbsp;&nbsp;Ultimas gu&iacute;as internacionales en monitorizaci&oacute;n cardiovascular<font color="#1f1a17" face="Courier New" size="2">    <br>  </font><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic.  Virginia Oxley</font><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.00 - 17.30&nbsp;&nbsp;&nbsp;&nbsp;Avances en intervencionismo cardiovascular y endovascular    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic.  Regina Yarza&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>Viernes 5 de diciembre&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>Sal&oacute;n: Ball Room A&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Prevenci&oacute;n primaria de muerte s&uacute;bita</b>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Alejandro Cuesta</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.20&nbsp;&nbsp;&nbsp;&nbsp;S&iacute;ndrome QT largo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gabriel Vanerio<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.20 - 08.40&nbsp;&nbsp;&nbsp;&nbsp;S&iacute;ndrome de Brugada<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Palmira Vanzini<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.40 - 09.00&nbsp;&nbsp;&nbsp;&nbsp;Displasia arritmog&eacute;nica<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Diego Freire<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.00 - 09.20&nbsp;&nbsp;&nbsp;&nbsp;Miocardiopat&iacute;a hipertr&oacute;fica<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Walter Reyes Caorsi<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>       <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.20 - 09.30&nbsp;&nbsp;&nbsp;&nbsp;Preguntas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font>    ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 09.30 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cardiopat&iacute;a isqu&eacute;mica dilatada</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Morillo (Canad&aacute;)</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Luis Vidal&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.30 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b>&nbsp; </font></p>      <p><font color="#1f1a17" face="Verdana" size="2"><b>&nbsp;&nbsp;&nbsp;Cardiopat&iacute;a isqu&eacute;mica en la mujer</b><i>&nbsp;</i> </font>  </p>     <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Coordinadoras: Dra. Carolina Artucio, Dra. Andrea Simeone&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia: Bayer&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 - 10.45&nbsp;&nbsp;&nbsp;&nbsp;Experiencia inicial y perspectiva del comit&eacute; de cardiopat&iacute;a en la mujer<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Carolina Artucio<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.45 - 11.00&nbsp;&nbsp;&nbsp;&nbsp;Casos cl&iacute;nicos representados con actores&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.00 - 11.15&nbsp;&nbsp;&nbsp;&nbsp;Estratificaci&oacute;n de riesgo en mujeres con s&iacute;ndrome coronario agudo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ram&oacute;n Gonz&aacute;lez Juanatey (Espa&ntilde;a)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.15 - 11.30&nbsp;&nbsp;&nbsp;&nbsp;An&aacute;lisis de diferencias de g&eacute;nero en el IAM con elevaci&oacute;n del ST tratado con     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;angioplastia en el infarto en el Uruguay<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Daniela Barranco<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.30 - 11.45&nbsp;&nbsp;&nbsp;&nbsp;Estr&oacute;genos, progestagenos y riesgo cardiovascular: visi&oacute;n desde la cardiolog&iacute;a&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. M&oacute;nica Acevedo (Chile)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.45 - 12.00&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dra. M&oacute;nica Giambruno, Dra. Virginia Michelis,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Anabela  Fern&aacute;ndez&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 12.00 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cardiopat&iacute;a isqu&eacute;mica en la mujer: presentaci&oacute;n cl&iacute;nica, diagn&oacute;stico y tratamiento</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dra. M&oacute;nica Acevedo (Chile)</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dra. M&oacute;nica Giambruno&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio Xarelto</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Ampliando horizontes en terapia antitromb&oacute;tica.</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Rivaroxaban en la enfermedad cardiovascular: a la luz de nuevas evidencias</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.30 - 12.50&nbsp;&nbsp;&nbsp;&nbsp;Rivaroxaban en fibrilaci&oacute;n auricular&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estudio ROCKET. Estudio X-VERT<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Pablo Asaduri&aacute;n<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>       <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.50 - 12.55&nbsp;&nbsp;&nbsp;&nbsp;Rivaroxaban en la vida real<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estudio XANTUS<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Roberto Laurens<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.55 - 13.15&nbsp;&nbsp;&nbsp;&nbsp;Rivaroxaban en sindrome coronario agudo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estudio ATLAS TIMI 51, discusi&oacute;n de casos cl&iacute;nicos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Oscar Bazzino<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;13.15 - 14.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Lunch cortes&iacute;a Bayer</b>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 14.00 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Coraz&oacute;n y diabetes</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><i>Coordinadores: Dr. Washington Vignolo, Dr. Bernardo Layerle</i>&nbsp; </font></p>      <p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;14.00 - 14.20&nbsp;&nbsp;&nbsp;&nbsp;Manejo de los factores de riesgo cardiovascular del diab&eacute;tico&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Washington Vignolo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.20 - 14.40&nbsp;&nbsp;&nbsp;&nbsp;Drogas hipoglucemiantes y sus efectos cardiovasculares&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Pilar Serra&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.40 - 15.00&nbsp;&nbsp;&nbsp;&nbsp;Revascularizaci&oacute;n en el diab&eacute;tico: &iquest;c&oacute;mo y a qui&eacute;n?&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Bernardo Layerle&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.00 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 15.30 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Actualizaci&oacute;n en hipertensi&oacute;n arterial</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ram&oacute;n Gonz&aacute;lez Juanatey (Espa&ntilde;a)</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Juan Alonso&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 16.00 - 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;&nbsp;16.30 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio Conjunto SUC - CCF</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Sociedad Uruguaya de Cardiolog&iacute;a - Cleveland Clinic Foundation</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Ariel Dur&aacute;n</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.30 - 16.50&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a en selecci&oacute;n de pacientes para TAVR<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Leonardo Rodr&iacute;guez (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.50 - 17.10&nbsp;&nbsp;&nbsp;&nbsp;Es posible aplicar las gu&iacute;as cl&iacute;nicas para prevenci&oacute;n de muerte s&uacute;bita en     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Uruguay. Responsabilidad &eacute;tica, social y econ&oacute;mica de los cardi&oacute;logos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Walter Reyes Caorsi&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.10 - 17.30&nbsp;&nbsp;&nbsp;&nbsp; C&oacute;mo descartar el s&iacute;ndrome coronario agudo en la sala de urgencia    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Conrad Simpfendorfer (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.30 - 17.50 &nbsp;&nbsp;&nbsp;&nbsp;Angioplastia Primaria en Uruguay. Resultados inmediatos y  a largo plazo     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jorge Mayol<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.50 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 18.00 - 18.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia Plenaria</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Puesta al d&iacute;a en s&iacute;ndromes coronarios agudos</b><i>&nbsp;</i> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dr. Eugene Braunwald (USA)</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Frank Torres&nbsp; </font></p>  <b>Sal&oacute;n: Conference&nbsp;</b>     <p><font color="#1f1a17" face="Verdana" size="2"> </font>  </p>     <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;El tracto de salida del VD en el postoperatorio alejado de la tetralog&iacute;a  de Fallot</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Pedro Chiesa, Dr. Pablo Carlevaro</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.20&nbsp;&nbsp;&nbsp;&nbsp;Aspectos cl&iacute;nicos&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Horacio Faella (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.20 - 08.40&nbsp;&nbsp;&nbsp;&nbsp;Valoraci&oacute;n ecocardiogr&aacute;fica. Qu&eacute; informaci&oacute;n se debe recabar<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Juan Carlos Gambetta<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.40 - 09.30&nbsp;&nbsp;&nbsp;&nbsp;Controversias en el manejo del Fallot operado<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n de casos cl&iacute;nicos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Alvaro Prieto, Dr. Gonzalo Segura, Dr. Sebasti&aacute;n Massaferro,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Mart&iacute;n  Sorondo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dra. Jacqueline Kreutzer (USA), Dr. Horacio Faella (Argentina),      <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ruben Leone, Dr. Dante Picarelli, Dr. Pedro Duhag&oacute;n,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Glausio Furlanetto  (Brasil), Dra. Beatriz Furlanetto (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 09.30 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Tratamiento percut&aacute;neo del tracto de salida del VD en el postoperatorio  alejado de Fallot</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dra. Jacqueline Kreutzer (USA)</i>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dra. Serrana Ant&uacute;nez&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.30 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Concurso</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cardiolog&iacute;a Cl&iacute;nica</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia Boehringer Ingelheim&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Bernardo Layerle, Dr. Washington Vignolo</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 14.00 - 14.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Novedades del ESC 2014</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dr. Michel Komajda (Francia)</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Fernando Kuster&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 14.30 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa SUC - SSC</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia Mitral isqu&eacute;mica</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Juan Jos&eacute; Paganini, Dra. Luc&iacute;a Florio</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidentes: Dr. Frank Torres (SUC), Dr. Roberto D&iacute;az del Castillo (SSC)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.30 - 14.50&nbsp;&nbsp;&nbsp;&nbsp;Historia natural de la insuficiencia mitral isqu&eacute;mica. Cl&iacute;nica y presentaci&oacute;n     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;del tratamiento m&eacute;dico&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Oscar Bazzino&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.50 - 15.10&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a card&iacute;aca para la insuficiencia mitral isqu&eacute;mica<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Leonardo Rodr&iacute;guez (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.10 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;Cirug&iacute;a card&iacute;aca en la insuficiencia mitral. &iquest;Cu&aacute;ndo operar? &iquest;Cu&aacute;ndo sustituir?<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Honorio Palma (Brasil)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>       <p align="left">&nbsp;<font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.30 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n caso cl&iacute;nico<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Alvaro Marichal<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Oscar Bazzino, Dr. Leonardo Rodr&iacute;guez (USA), &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Honorio Palma (Brasil), Dr. Jorge Mayol ,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Roberto D&iacute;az del Castillo (Colombia)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; &nbsp;16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; &nbsp;16.30 &ndash; 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp; &nbsp;&nbsp; Insuficiencia card&iacute;aca</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Pablo Alvarez Rocha</i>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 - 16.45&nbsp;&nbsp;&nbsp;&nbsp;Datos de la Unidad Multidisciplinaria de Insuficiencia Card&iacute;aca     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;del Hospital de Cl&iacute;nicas&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Gabriela Ormaechea<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.45 - 16.55&nbsp;&nbsp;&nbsp;&nbsp;Caso cl&iacute;nico<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Juan Torrado<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.55 - 17.15&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia card&iacute;aca aguda. Una visi&oacute;n trasatl&aacute;ntica&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ram&oacute;n Gonz&aacute;lez Juanatey (Espa&ntilde;a)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.15 - 17.25&nbsp;&nbsp;&nbsp;&nbsp;Caso cl&iacute;nico<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Camila Ramos&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.25 - 17.45&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia card&iacute;aca: &eacute;xitos y fracasos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Michel Komajda (Francia)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.45 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">     <br>  </font><font color="#1f1a17" face="Verdana" size="2"> <b>Sal&oacute;n: Picasso&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>XXV JORNADAS SOLACI</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>Presidente: Dr. Pedro Trujillo</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.15 &ndash; 08.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Palabras de Apertura&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente XXV Jornadas SOLACI - Regi&oacute;n Cono Sur: Dr. Pedro Trujillo:&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente Jornadas SOLACI: Dr. Pedro Hidalgo (Venezuela)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Vice-Presidente SOLACI: Dr. Ricardo Lluberas&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.30 &ndash; 10.00<b>&nbsp;&nbsp;&nbsp;&nbsp;</b><b>M&oacute;dulo </b><b>&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Intervencionismo coronario I</b><i><b>&nbsp;</b></i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia: ALVIM&Eacute;DICA&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Pablo V&aacute;zquez, Dra. Ivanna Duro</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: &nbsp;&nbsp;Dr. Gilberto Nunes (Brasil), Dr. Anibal Damonte (Argentina),  Dr. Rafael Mila,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Benitez (Paraguay), Dr. Pablo D&iacute;az&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.30 - 08.45&nbsp;&nbsp;&nbsp;&nbsp;Revascularizaci&oacute;n de lesiones residuales luego de un infarto&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Conrad Simpfendorfer (USA)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.45 - 09.00&nbsp;&nbsp;&nbsp;&nbsp;Lesiones intermedias en la pr&aacute;ctica diaria&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Daniel Berrocal (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.00 - 09.15&nbsp;&nbsp;&nbsp;&nbsp;Intervenciones coronarias en el paciente con fibrilaci&oacute;n auricular&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Conrad Simpfendorfer (USA)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.15 - 09.23&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 1: Tomograf&iacute;a de coherencia &oacute;ptica en una bifurcaci&oacute;n &nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Everardo Lozano (M&eacute;xico)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.23 - 09.35&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.35 - 09.43&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 2: Abordaje retr&oacute;grado de oclusi&oacute;n cr&oacute;nica de coronaria derecha&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Fernando Cohen (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.43 - 09.55&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.55 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;Comentarios&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: &nbsp;Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.30 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;<b>M&oacute;dulo </b><b>&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Intervencionismo coronario II</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. C&eacute;sar Pardi&ntilde;as, Dr. Tom&aacute;s Dieste</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Conrad Simpfendorfer (USA), Dr. Daniel Berrocal (Argentina),      <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Pedro Hidalgo (Venezuela), Dr. Andr&eacute;s Tuzman, Dr. Gustavo Vignolo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 - 10.45&nbsp;&nbsp;&nbsp;&nbsp;Angioplastia de tronco coronario izquierdo. Perspectiva&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gilberto Nunes (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.45 - 10.53&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 3: ATC de TCI no protegido guiado por IVUS&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gilberto Del Campo Ortega (M&eacute;xico)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.53 - 11.10&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>       <p align="left">&nbsp;<font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.10 - 11.25&nbsp;&nbsp;&nbsp;&nbsp;Angioplastia de m&uacute;ltiples vasos&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gilberto Nunes (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.25 - 11.40&nbsp;&nbsp;&nbsp;&nbsp;Estrategias de estudio y revascularizaci&oacute;n en el paciente  con cirug&iacute;a de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;bypass coronaria previa&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Hugo Londero (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.40 - 11.48&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 4: Manejo de aneurisma de puente venoso &nbsp;ADA &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Lucas Romero (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.48 - 12.00&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 12.00 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Intervalo<b>&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 14.00 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>M&oacute;dulo </b><b>- Parte I</b><b>&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b></b><i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Simposio de Residentes LATAM de Hemodinamia - SOLACI </b><i><b>&nbsp;</b></i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia: Abbott&nbsp;&nbsp;&nbsp;&nbsp;<i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Pedro Trujillo, Dr. Daniel Berrocal  (Argentina)</i>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Hugo Londero (Argentina), Dr. Anibal Damonte (Argentina),      <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Ricardo Lluberas, Dr. Roberto Botelho (Brasil), Dr. Pablo V&aacute;zquez&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 - 14.05&nbsp;&nbsp;&nbsp;&nbsp;Introducci&oacute;n&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.05 - 14.15&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 5: Valvuloplastia a&oacute;rtica y ATC de TCI en shock cardiog&eacute;nico&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Miguel Sorondo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.15 - 14.25&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.25 - 14.35&nbsp;&nbsp;&nbsp;&nbsp;Caso C&iacute;nico 6: Valvuloplastia a&oacute;rtica en la era de la TAVI &nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Sebasti&aacute;n Lluberas&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.35 - 14.45&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.45 - 14.55&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 7: TAVI transapical&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Andr&eacute;s Nehme (Argentina)&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.55 - 15.05&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.05 - 15.15&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 8: TAVI transapical&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Pablo Spaletra (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.15 - 15.25&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.25 - 15.35&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 9: F&iacute;stula coronaria. Arteria pulmonar&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Aldana Victor Gil (Colombia)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.35 - 15.45&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: &nbsp;Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 16.30 &ndash; 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>M&oacute;dulo </b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Miscel&aacute;neas en intervencionismo</b><i><b>&nbsp;</b></i> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Daniel Mallo, Dr. Ignacio Batista</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Gilberto Nunes (Brasil), Dr. Hugo Londero (Argentina),  Dra. &nbsp;Carolina Artucio,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Pedro Hidalgo (Venezuela)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.30 - 16.45&nbsp;&nbsp;&nbsp;&nbsp;Estado actual del cierre de orejuela izquierda&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Anibal Damonte (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.45 - 16.53&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 10: Cierre de orejuela izquierda&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Ignacio Batista&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.53 - 17.10&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.10 - 17.25&nbsp;&nbsp;&nbsp;&nbsp;Revascularizaci&oacute;n percut&aacute;nea coronaria, aplicaci&oacute;n de los &uacute;ltimos avances     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;en Latinoam&eacute;rica&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Hugo Londero (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.25 - 17.40&nbsp;&nbsp;&nbsp;&nbsp;Scaffold bioabsorbibles. Estado actual y proyecci&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Roberto Botelho (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.40 - 17.48&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 11: Tratamiento de aneurisma de coronaria derecha     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;con stent MGuard&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Dayana Acosta&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.48 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>       <p align="left">&nbsp;<font color="#1f1a17" face="Verdana" size="2"><b>Sal&oacute;n: Matisse&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Presentaci&oacute;n E-posters</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cardiolog&iacute;a Cl&iacute;nica</b>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Pablo Asaduri&aacute;n, Dr. Sergio Montenegro (Brasil), Dra.  Virginia Michelis&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;3&nbsp;&nbsp;&nbsp;&nbsp;Relevancia Cl&iacute;nica del ecocardiograma transesof&aacute;gico en pacientes con ataque cerebrovascular isqu&eacute;mico. Estudio&nbsp;observacional, anal&iacute;tico.<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Luc&iacute;a Florio&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.15 - 08.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;8&nbsp;&nbsp;&nbsp;&nbsp;Validaci&oacute;n de la enfermedad vascular carotidea como&nbsp;marcador de enfermedad coronaria e isquemia inducible en pacientes asintom&aacute;ticos con m&uacute;ltiples factores de riesgo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Victor Martir&eacute;<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.30 - 08.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;9&nbsp;&nbsp;&nbsp;&nbsp;La implementaci&oacute;n del sistema de gesti&oacute;n de calidad: &nbsp;&nbsp;&nbsp;HIPERGEST &reg;, determina un mejor control de la hipertensi&oacute;n arterial en la paciente embarazada y gran impacto cl&iacute;nico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sobre la morbimortalidad materno-fetal&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Victor Martir&eacute;<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.45 - 09.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;10&nbsp;&nbsp;&nbsp;&nbsp;El test de fr&iacute;o como apremio en estudios de perfusi&oacute;n mioc&aacute;rdica, evidencia mayor monto isqu&eacute;mico en pacientes con lesiones coronarias intermedias&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Victor Martir&eacute;<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.00 - 09.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;11&nbsp;&nbsp;&nbsp;&nbsp;&iquest;Son los consumidores de coca&iacute;na y pasta base de&nbsp;coca&iacute;na comparables a la poblaci&oacute;n normal en sus valores&nbsp;ecocardiogr&aacute;ficos?&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Luc&iacute;a Florio<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.15 - 09.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;17&nbsp;&nbsp;&nbsp;&nbsp;Anticoagulaci&oacute;n oral con warfarina en pacientes con&nbsp;insuficiencia card&iacute;aca<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Stephan&iacute;a Peixoto&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.30 - 09.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;24&nbsp;&nbsp;&nbsp;&nbsp;Evaluaci&oacute;n del test de tilt antes y despu&eacute;s del cambio en la poblaci&oacute;n de referencia asistida&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Adriana Rodr&iacute;guez<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.45 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;28&nbsp;&nbsp;&nbsp;&nbsp;Cambio de paradigma en el uso de biomarcadores de injuria cardiaca en puerta de emergencia luego de&nbsp;intervenci&oacute;n educativa. Primera experiencia nacional&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Federico Machado&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.00 - 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.30 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Presentaci&oacute;n E-posters</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Prevenci&oacute;n y Rehabilitaci&oacute;n</b><i>&nbsp;</i> </font></p>      ]]></body>
<body><![CDATA[<p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dra. Mar&iacute;a Dutra, Dra. Mar&iacute;a del Pilar Aguilar, Dr. Carlos  Berm&uacute;dez&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 - 10.45 &nbsp;&nbsp;&nbsp;&nbsp;N&deg;12&nbsp;&nbsp;&nbsp;&nbsp;Impacto de un programa de rehabilitaci&oacute;n card&iacute;aca sobre par&aacute;metros metab&oacute;licos y funcionales del paciente coronario obeso&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gerard Burdiat<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.45 - 11.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;13&nbsp;&nbsp;&nbsp;&nbsp;Conocimiento del perfil lip&iacute;dico en pacientes coronarios dislip&eacute;micos que ingresan a un programa de Prevenci&oacute;n Secundaria / Rehabilitaci&oacute;n Card&iacute;aca<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gerard Burdiat&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp; 11.00 - 11.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;18&nbsp;&nbsp;&nbsp;&nbsp;Capacidad funcional de hombres y mujeres sometidos a rehabilitaci&oacute;n card&iacute;aca&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gerard Burdiat<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.15 - 11.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;37&nbsp;&nbsp;&nbsp;&nbsp;Uso de estatinas en prevenci&oacute;n secundaria y su efecto en el LDL-c&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Lorena Vi&ntilde;ole&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.30 - 11.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;41&nbsp;&nbsp;&nbsp;&nbsp;Prevenci&oacute;n secundaria en el Infarto agudo con supradesnivel del     ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;segmento ST: de las gu&iacute;as a la pr&aacute;ctica cl&iacute;nica&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Sebasti&aacute;n Lorenzo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Electrofisiolog&iacute;a</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Carlos Morillo (Canad&aacute;), Dr. Gonzalo Varela, Dr. Luis  Vidal&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.45 - 12.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;6&nbsp;&nbsp;&nbsp;&nbsp;Experiencia de la Terapia de Resincronizaci&oacute;n Card&iacute;aca en una     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unidad de Insuficiencia Card&iacute;aca desde una perspectiva cl&iacute;nica&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gabriel Parma&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.00 - 12.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;22&nbsp;&nbsp;&nbsp;&nbsp;Estudio de variantes gen&egrave;ticas relacionados con muerte s&uacute;bita     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;en lactantes fallecidos de forma inesperada y sin diagn&oacute;stico<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alejandro Cuesta&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.15 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;23&nbsp;&nbsp;&nbsp;&nbsp;Hallazgos en el estudio exhaustivo de pacientes entre 1 y 25 a&ntilde;os    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;fallecidos de forma s&uacute;bita<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Pedro Chiesa&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;12.30 - 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;14.00 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Presentaci&oacute;n E-posters</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Ecocardiograf&iacute;a&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Diego P&eacute;rez de Arenaza (Argentina), Dr. Juan Bautista  Gonz&aacute;lez Moreno,    <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Alvaro B&aacute;ez&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 - 14.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;4&nbsp;&nbsp;&nbsp;&nbsp;Caracterizaci&oacute;n de la aorta ascendente en poblaci&oacute;n uruguaya sana.     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Descripci&oacute;n de un patr&oacute;n fenot&iacute;pico propio&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gabriel Parma<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.15 - 14.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;14&nbsp;&nbsp;&nbsp;&nbsp;Prevalencia de insuficiencia tricusp&iacute;dea y mitral en una poblaci&oacute;n sana    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Uruguaya. &iquest;Un hallazgo frecuente?<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gabriel Parma&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.30 - 14.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;15&nbsp;&nbsp;&nbsp;&nbsp;Primer reporte de valores normales en uruguayos de strain longitudinal     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;global del ventr&iacute;culo izquierdo y derecho por Vector Velocity Imaging&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gabriel Parma&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cardiolog&iacute;a Nuclear</b><i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dra. Mariela Lujambio, Dr. Gabriel Grossman (Brasil), Dr.  Federico Ferrando<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>       <p align="left">&nbsp;    ]]></body>
<body><![CDATA[<br> <font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.45 - 15.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;31&nbsp;&nbsp;&nbsp;&nbsp;Correlaci&oacute;n an&aacute;tomo-funcional entre estudios de perfusi&oacute;n mioc&aacute;rdica    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;de alto riesgo y la coronariograf&iacute;a&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Nicol&aacute;s Niell&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.00 - 15.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;32&nbsp;&nbsp;&nbsp;&nbsp;La diabetes se asocia a riesgo elevado de eventos card&iacute;acos m&aacute;s all&aacute;     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;de la mayor&iacute;a de variables de estudios de perfusi&oacute;n mioc&aacute;rdica con     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dipiridamol&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Cecilia Bentancourt&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.15 - 15.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;38&nbsp;&nbsp;&nbsp;&nbsp;SPECT de perfusi&oacute;n mioc&aacute;rdica en la evaluaci&oacute;n de mujeres con SCA     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;probable&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Erika Mirandetti&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.30 - 15.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;40&nbsp;&nbsp;&nbsp;&nbsp;Taquicardia Ventricular desencadenada por el estr&eacute;s: frecuencia y     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;significaci&oacute;n isqu&eacute;mica&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. In&eacute;s Vidal&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.45 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;52&nbsp;&nbsp;&nbsp;&nbsp;La respuesta de la frecuencia cardiaca durante la infusi&oacute;n de     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dipiridamol se asocia con la tasa de eventos en&nbsp;pacientes con estudio de perfusi&oacute;n normal&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Cecilia Bentancourt&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 16.00 - 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 16.30 - 17.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Presentaci&oacute;n E-posters</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cirug&iacute;a Card&iacute;aca</b>&nbsp;&nbsp;&nbsp;&nbsp;<i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Roberto D&iacute;az del Castillo (Colomia), Dr. Roberto Stanham,      ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Honorio Palma (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 - 16.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;7&nbsp;&nbsp;&nbsp;&nbsp;El mismatch pr&oacute;tesis-paciente luego de la sustituci&oacute;n valvular a&oacute;rtica     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no se asocia a mortalidad operatoria&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Victor Dayan<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.45 - 17.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;34&nbsp;&nbsp;&nbsp;&nbsp;Impacto del clopidogrel en pacientes con s&iacute;ndrome coronario agudo e     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;indicaci&oacute;n de cirug&iacute;a de revascularizaci&oacute;n mioc&aacute;rdica de urgencia<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Anal&iacute;a Kotogian&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.00 - 17.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;36&nbsp;&nbsp;&nbsp;&nbsp;Cirug&iacute;a de revascularizaci&oacute;n mioc&aacute;rdica con las dos arterias mamarias.    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estudio comparativo de mortalidad operatoria y sobrevida a largo plazo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Luc&iacute;a Dalto<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.15 - 17.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;44&nbsp;&nbsp;&nbsp;&nbsp;Evaluaci&oacute;n de los factores de riesgo de infecci&oacute;n profunda de     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;esternotomia en post operatorio de cirug&iacute;a cardiaca&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Maximiliano De Le&oacute;n&nbsp; </font></p>       <p align="left"><font color="#1f1a17" face="Verdana" size="2"> </font><font color="#1f1a17" face="Verdana" size="2"><b>Sal&oacute;n: Ball Room C&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio Comit&eacute; Imagen Cardiovascular - Parte I</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Qu&eacute; nos aportan las t&eacute;cnicas de imagen para el estudio cl&iacute;nico de los     <br>  &nbsp;&nbsp;&nbsp;&nbsp;pacientes  con insuficiencia card&iacute;aca</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinador General: Dr. Sergio Tantessio</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.20&nbsp;&nbsp;&nbsp;&nbsp;Inauguraci&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.20 - 08.40&nbsp;&nbsp;&nbsp;&nbsp;Valor del eco Doppler en el diagn&oacute;stico y pron&oacute;stico de la insuficiencia card&iacute;aca<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Marcia Barbosa (Brasil)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Dra. Ver&oacute;nica Gonz&aacute;lez</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.45 - 09.05&nbsp;&nbsp;&nbsp;&nbsp;Cardiopat&iacute;a isqu&eacute;mica como causa de insuficiencia card&iacute;aca: c&oacute;mo nos puede    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ayudar la medicina nuclear y la tomograf&iacute;a card&iacute;aca&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gabriel Grossman (Brasil)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Fernando Mut</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.10 - 09.30&nbsp;&nbsp;&nbsp;&nbsp;Resonancia magn&eacute;tica card&iacute;aca en al evaluaci&oacute;n de miocardiopat&iacute;as&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Diego P&eacute;rez de Arenaza (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Carlos Gonz&aacute;lez Tr&iacute;as</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.35 - 09.55&nbsp;&nbsp;&nbsp;&nbsp;Tomograf&iacute;a card&iacute;aca en el paciente con asistencia mec&aacute;nica&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Leonardo Rodr&iacute;guez (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Dra. Alicia Panzacchi</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.30 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio Comit&eacute; Imagen Cardiovascular - Parte II</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a card&iacute;aca para el an&aacute;lisis de viabilidad mioc&aacute;rdica. C&oacute;mo &nbsp;estudio a mi paciente</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador General: Dr. Sergio Tantessio</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dra. Marcia Barbosa (Brasil), Dr. Leonardo Rodr&iacute;guez (USA),      <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. &nbsp;Gabriel Grossman (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 - 10.50&nbsp;&nbsp;&nbsp;&nbsp;Utilidad de ecostress m&aacute;s all&aacute; de la detecci&oacute;n de viabilidad de un segmento&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jos&eacute; P&eacute;rez Arrarte&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Enrique Dom&iacute;nguez&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.50 - 11.10&nbsp;&nbsp;&nbsp;&nbsp;Valor del PET en la evaluaci&oacute;n de viabilidad mioc&aacute;rdica&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Fernando Mut<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Miguel Kapit&aacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.10 - 11.30&nbsp;&nbsp;&nbsp;&nbsp;Estudio actual de la viabilidad mioc&aacute;rdica por resonancia  magn&eacute;tica&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Diego P&eacute;rez de Arenaza (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Carlos Gonz&aacute;lez Tr&iacute;as<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.30 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos<font color="#1f1a17" face="Courier New" size="2">    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font color="#1f1a17" face="Verdana" size="2">Coordinadores: Dr. Carlos Gonz&aacute;lez Tr&iacute;as, Dr.  Fernando Mut</font><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadores: Dr. Le&oacute;n Mu&ntilde;oz, Dra. Cecilia Bentancourt&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 14.00 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio Arritmolog&iacute;a</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Actualizaci&oacute;n del tratamiento mediante ablaci&oacute;n</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Luis Vidal&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.00 - 14.20&nbsp;&nbsp;&nbsp;&nbsp;Registro Uruguayo de Ablaci&oacute;n - SOLAECE&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Alejandro Cuesta<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.20 - 14.40&nbsp;&nbsp;&nbsp;&nbsp;Ablaci&oacute;n de fibrilaci&oacute;n auricular en Uruguay<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gonzalo Varela<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.40 - 15.00&nbsp;&nbsp;&nbsp;&nbsp;Novedades en ablaci&oacute;n de fibrilaci&oacute;n auricular<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Morillo (Canad&aacute;)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.00 - 15.20&nbsp;&nbsp;&nbsp;&nbsp;Ablaci&oacute;n de taquicardia ventricular en Uruguay<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gustavo Olveira<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.20 - 15.40&nbsp;&nbsp;&nbsp;&nbsp;Novedades en ablaci&oacute;n de taquicardia ventricular<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Morillo (Canad&aacute;)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.40 - 16.00&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;16.30 &ndash; 18.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a cardiovascular con &eacute;nfasis en medicina nuclear</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Federico Ferrando</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 - 17.00&nbsp;&nbsp;&nbsp;&nbsp;La cardiolog&iacute;a nuclear para evaluar posible coronariopat&iacute;a en pacientes     ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;con disfunci&oacute;n sist&oacute;lica del VI&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gabriel Grossman (Brasil)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.00 - 18.00&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Juan Carlos Hermida, Dr. Miguel Kapit&aacute;n, Dr. Roberto Ricca, Dra. Mariela Lujambio&nbsp; </font></p>  &nbsp; &nbsp;<b>S&aacute;bado 6 de diciembre&nbsp;</b>     <p><font color="#1f1a17" face="Verdana" size="2"> </font> </p>     <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp; &nbsp;Sal&oacute;n: Ball Room A&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; 08.00 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;Hipertensi&oacute;n pulmonar</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Pedro Trujillo, Dr. Juan Carlos Grignola</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.20&nbsp;&nbsp;&nbsp;&nbsp;Hipertensi&oacute;n pulmonar en cardiopat&iacute;as cong&eacute;nitas del adulto&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Jacqueline Kreutzer (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.20 - 09.00&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dra. Jacqueline Kreutzer (USA), Dra. Pilar Escribano (Espa&ntilde;a),     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Pedro Chiesa, Dr. Juan Carlos Grignola, Dra. Gabriela Pascal,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Pablo  Curbelo, Dr. Pedro Trujillo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.00 - 09.20&nbsp;&nbsp;&nbsp;&nbsp;Ventr&iacute;culo derecho y post operatorio de cirug&iacute;a card&iacute;aca y no &nbsp;card&iacute;aca<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Pilar Escribano (Espa&ntilde;a)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.20 - 09.30&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dra. Jacqueline Kreutzer (USA), Dra. Pilar Escribano (Espa&ntilde;a),     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Juan Carlos Grignola, Dra. Gabriela Pascal, Dr. Pedro Trujillo, Dr.  Leandro Cura&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 09.30 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp; &nbsp; Esquema de tratamiento de la hipertensi&oacute;n pulmonar</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dra. Pilar Escribano (Espa&ntilde;a)</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dra. Gabriela Pascal&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia: Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.00 - 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.30 - 12.00&nbsp;&nbsp;&nbsp;&nbsp;<b>XXV Jornadas Rioplatenses de Cardiolog&iacute;a (SUC - SAC)</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;S&iacute;ndromes Coronarios Agudos</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Pablo D&iacute;az, Dr. Frank Torres</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidentes: Dr. Frank Torres (SUC), Dr. Carlos Tajer (SAC)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 - 10.50&nbsp;&nbsp;&nbsp;&nbsp;Reperfusi&oacute;n en el Uruguay&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Frank Torres&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.50 - 11.10&nbsp;&nbsp;&nbsp;&nbsp;Infarto agudo de miocardio: &iquest;cu&aacute;ndo utilizar la estrategia f&aacute;rmaco-invasiva?&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Conrad Simpfendorfer (USA)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.10 - 11.40&nbsp;&nbsp;&nbsp;&nbsp;Controversias: infarto agudo de miocardio en enfermedad multivaso:      <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&iquest;revascularizaci&oacute;n de vaso culpable o revascularizaci&oacute;n completa?<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gustavo Junker vs. Dr. Carlos Benitez (Paraguay)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.40 - 12.00&nbsp;&nbsp;&nbsp;&nbsp;Calidad de vida y rehabilitaci&oacute;n psicosocial post SCA; rol  del cardi&oacute;logo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Tajer (Argentina)&nbsp; </font></p>       <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>Sal&oacute;n: Conference&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> 08.00 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Trabajos Premiados</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Carlos Romero&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Tribunal: Dr. Ram&oacute;n Gonz&aacute;lez Juanatey (Espa&ntilde;a), Dr. Leonardo Rodr&iacute;guez  (USA),     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Romero, Dr. Conrad Simpfendorfer (USA), Dr. Carlos Tajer  (Argentina)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;2&nbsp;&nbsp;&nbsp;&nbsp;Resultados y predictores para el mismatch pr&oacute;tesis-paciente a&oacute;rtico.     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Meta-an&aacute;lisis de 40,381 pacientes&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Victor Dayan<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.15 - 08.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;20&nbsp;&nbsp;&nbsp;&nbsp;1er Registro Nacional De Ablaci&oacute;n de Arritmias Card&iacute;acas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alejandro Cuesta&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.30 - 08.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;42&nbsp;&nbsp;&nbsp;&nbsp;Percepci&oacute;n de calidad de vida antes y despu&eacute;s de la cirug&iacute;a de     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;revascularizaci&oacute;n mioc&aacute;rdica a trav&eacute;s de cuestionarios SF-36 y DASI<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Natalia Esmite&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.45 - 09.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;45&nbsp;&nbsp;&nbsp;&nbsp;La obesidad infantil y adolescente asocia remodelado arterial, aumento    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; de rigidez y presi&oacute;n a&oacute;rtica, y reducci&oacute;n de la funci&oacute;n endotelial y la     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amplificaci&oacute;n del pulso&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Victoria Garc&iacute;a<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.00 - 09.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;46&nbsp;&nbsp;&nbsp;&nbsp;Prevalencia de alteraciones estructurales y funcionales arteriales en     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;327 ni&ntilde;os uruguayos asintom&aacute;ticos, evaluados en un nuevo centro     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pedi&aacute;trico preventivo<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Santiago Curcio&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.15 - 09.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;47&nbsp;&nbsp;&nbsp;&nbsp;Exposici&oacute;n a radiaci&oacute;n del cardi&oacute;logo intervencionista. Acceso radial     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;derecho (ARD) versus acceso radial izquierdo (ARI)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Ignacio Batista<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.30 - 09.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;51&nbsp;&nbsp;&nbsp;&nbsp;Cambios en el perfil y din&aacute;mica de la reactividad vascular asociados a     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;terapia de resincronizaci&oacute;n card&iacute;aca: &iquest;se &nbsp;&ldquo;despiertan&rdquo; el endotelio y    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; m&uacute;sculo liso arterial?<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Yanina Z&oacute;calo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.00 - 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.30 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>V Jornadas Rioplatenses de Cardi&oacute;logos en Formaci&oacute;n (CCFUR  &ndash; CONAREC)</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;CardiOlimp&iacute;adas</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia: Roemmers&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dra. Florencia Di Landro, Dra. Andreina G&oacute;mez, Dr. Gustavo  Vignolo</i>&nbsp; </font></p>      <p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;Participantes: Dr. Sebasti&aacute;n Albistur, Dr. Ezequiel Besmalinovich (Argentina),     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dra. Natalia Esmite, Dr. Luciano Fallabrino (Argentina), Dra. Luc&iacute;a Florio,  Dra. Valentina Lanz,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Jos&eacute; Anibal Manfredi, Dr. Rafael Mila, Dra. Fabiana  Narbondo, Dra. Sof&iacute;a Noria,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Pablo Spaletra (Argentina), Dra. Lorena  Vi&ntilde;ole&nbsp; </font>  </p>     <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 12.30 - 13.00&nbsp;&nbsp;&nbsp;&nbsp;Entrega de Premios<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Mejor Tema Libre</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado e inscripci&oacute;n al Congreso Espa&ntilde;ol de Cardiolog&iacute;a 2015&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Premio Pfizer: Mejor Tema Libre al Investigador Joven</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, inscripci&oacute;n y alojamiento al Congreso Espa&ntilde;ol de Cardiolog&iacute;a  2015&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Tema Libre Destacado 1</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2015&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Tema Libre Destacado 2</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2015&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Tema Libre Destacado 3</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2015&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Tema Libre Destacado 4</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2015&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Tema Libre Destacado 5</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2015&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;13.00 - 13.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia de Clausura</b>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;10 avances que han definido a la cardiolog&iacute;a moderna</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dr. Eugene Braunwald (USA)</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Ariel Dur&aacute;n&nbsp; </font></p>       <p align="left">&nbsp; &nbsp; &nbsp;<font color="#1f1a17" face="Verdana" size="2"><b>Sal&oacute;n: Picasso&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; XXV JORNADAS SOLACI<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; Presidente: Dr. Pedro Trujillo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 08.00 - 10.00<b>&nbsp;&nbsp;&nbsp;&nbsp;M&oacute;dulo </b><b>- Parte II</b><b>&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b></b><i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Simposio de Residentes LATAM de Hemodinamia - SOLACI </b><i><b>&nbsp;</b></i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Jorge Mayol, Dr. Pedro Hidalgo (Venezuela)</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Daniel Berrocal (Argentina), Dr. Gilberto Nunes (Brasil),      <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Hugo Londero (Argentina), Dr. Roberto Botelho (Brasil), Dr. Tom&aacute;s Dieste&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.10&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 12: Trombofragmentaci&oacute;n en TEP masivo&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alex Rocha&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.10 - 08.20&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.20 - 08.30&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 13: Tratamiento endovascular de una trombosis      <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;venosa profunda&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Juan Manuel Telayna (Argentina)&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.30 - 08.40&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.40 - 08.50&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 14: Cierre con Amplatzer de seudoaneurisma a&oacute;rtico&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Dahiana Ibarrola (Paraguay)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.50 - 09.00&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.00 - 09.10&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 15: Valve in valve tricusp&iacute;dea&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Luis Areiza (Colombia)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.10 - 09.20&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.20 - 09.30&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 16: Cierre de leak mitral&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gustavo Pedernera (Argentina)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.30 - 09.40&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.40 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;Comentarios finales&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.00 - 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: &nbsp;Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> 10.30 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>M&oacute;dulo </b><b>&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Implante percut&aacute;neo de v&aacute;lvula a&oacute;rtica</b><i><b>&nbsp;</b></i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Ricardo Lluberas, Dr. Jorge Mayol</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Anibal Damonte (Argentina), Dr. Hugo Londero (Argentina),      <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Gilberto Nunes (Brasil), Dr. Honorio Palma (Brasil), Dr. &nbsp;Mario Araya  (Chile)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 - 10.35&nbsp;&nbsp;&nbsp;&nbsp;Introducci&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.35 - 10.50&nbsp;&nbsp;&nbsp;&nbsp;Implante de v&aacute;lvula a&oacute;rtica transcat&eacute;ter. &iquest;D&oacute;nde estamos y ad&oacute;nde vamos?&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Daniel Berrocal (Argentina)&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.50 - 11.00&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 17: TAVI en v&aacute;lvula a&oacute;rtica bic&uacute;side&nbsp; </font></p>      <p><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Rodrigo Mu&ntilde;oz (Chile)&nbsp; </font>  </p>     <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.00 - 11.15&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.15 - 11.30&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a en la estenosis a&oacute;rtica pre, intra y post TAVI&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Leonardo Rodr&iacute;guez (USA)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.30 - 11.45&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n con el panel&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.45 - 12.00&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;El calcio amigo o enemigo&rdquo; en el implante percut&aacute;neo de v&aacute;lvula a&oacute;rtica&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Pedro Hidalgo (Venezuela)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.00 - 12.10&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico 18: TAVI por acceso no convencional&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Santiago Alonso&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.10 - 12.25&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.25 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;Cierre de las Jornadas SOLACI&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Entrega de Premio: &ldquo;Mejor Caso Fellow LATAM&rdquo;<i>&nbsp;</i> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> </font><font color="#1f1a17" face="Verdana" size="2"><b>&nbsp; &nbsp; &nbsp;Sal&oacute;n: Ball Room C&nbsp;</b> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp; 08.00 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa</b><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Revascularizaci&oacute;n mioc&aacute;rdica en el 2014</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dr. Hugo Pi&ntilde;eyro, Dra. Ivanna Duro</i>&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 - 08.20&nbsp;&nbsp;&nbsp;&nbsp;Tratamiento m&eacute;dico agresivo. &iquest;Puede ser un sustituto de la revascularizaci&oacute;n?&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Sergio Montenegro (Brasil)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.20 - 08.40&nbsp;&nbsp;&nbsp;&nbsp;Integraci&oacute;n de los hallazgos de la cardiolog&iacute;a nuclear con la ergometr&iacute;a<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gabriel Grossman (Brasil)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.40 - 09.10&nbsp;&nbsp;&nbsp;&nbsp;Angioplastia multiarterial, &iquest;cu&aacute;ndo, a qui&eacute;nes? Basada en los &uacute;ltimos trials<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Ben&iacute;tez (Paraguay)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.10 - 09.30&nbsp;&nbsp;&nbsp;&nbsp;La cirug&iacute;a coronaria a la luz del Syntax: &iquest;sigue siendo el gold standard?<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Honorio Palma (Brasil)<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.30 - 10.00&nbsp;&nbsp;&nbsp;&nbsp;Preguntas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Pablo D&iacute;az, Dr. Gustavo Junker, Dr. Sergio Montenegro (Brasil),    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.  Roberto D&iacute;az del Castillo (Colombia)&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.00 - 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2">&nbsp; &nbsp;10.30 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio Arritmolog&iacute;a</b>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Aportes desde diversas disciplinas</b><font color="#1f1a17" face="Courier New" size="2"><i>&nbsp;</i></font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Alejandro Cuesta</i><font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 - 10.50&nbsp;&nbsp;&nbsp;&nbsp;Bases moleculares de las arritmias gen&eacute;ticas&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Rosario Guaicambur&uacute;<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.50 - 11.10&nbsp;&nbsp;&nbsp;&nbsp;Bases anat&oacute;micas de las arritmias con sustrato<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Carmen Guti&eacute;rrez<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.10 - 11.30&nbsp;&nbsp;&nbsp;&nbsp;Desde el gen hasta el ECG<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gonzalo Ferreira&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.30 - 11.50&nbsp;&nbsp;&nbsp;&nbsp;Qu&eacute; ofrece la imagenolog&iacute;a TAC - RMC&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Natalia Lluberas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.50 - 12.10&nbsp;&nbsp;&nbsp;&nbsp;Sistemas de navegaci&oacute;n no radiol&oacute;gicas&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gustavo Tortajada&nbsp; </font></p>      <p align="left"><font color="#1f1a17" face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.10 - 12.30&nbsp;&nbsp;&nbsp;&nbsp;Preguntas<font color="#1f1a17" face="Courier New" size="2">&nbsp;</font> </font></p>      <p>  </p>      ]]></body>
</article>
